— Know what they know.
Not Investment Advice

BIM.PA

bioMérieux S.A.
1W: -1.4% 1M: -4.3% 3M: -15.1% YTD: -3.1% 1Y: -19.3% 3Y: +1.1% 5Y: -10.4%
€90.45 ($104.59)
-0.65 (-0.71%)
 
PAR · Healthcare · Medical - Diagnostics & Research · €10.7B · Alpha Radar Sell · Power 38
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap€10.7B ($12.4B)
52W Range90.25-128.3
Volume102,959
Avg Volume134,636
Beta0.66
Dividend€0.90
Analyst Ratings
No analyst coverage
Company Info
CEOPierre Boulud
Employees14,147
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2004-07-07
376 Chemin De l'Orme
Marcy l'Étoile 69280
FR
33 4 78 87 20 00
About bioMérieux S.A.

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms